Wed, 25 Feb 2026
|DHIVEHI
MET warns haze to persist across Maldives over next five days
25 Feb 2026
|
Hazy conditions in Malé --- Photo: MMTV
The Maldives Meteorological Service (MET) has warned that haze conditions affecting air quality across the country are expected to persist over the next five days, with reduced visibility and poorer air quality reported across several atolls, particularly in the northern and central regions.
In an update shared on Wednesday, MET said visibility in parts of the northern atolls has fallen to below two kilometres due to persistent haze, and that prevailing regional atmospheric conditions are expected to sustain hazy weather nationwide over the coming days. The MET Office advised seafarers and individuals who spend extended periods outdoors to take necessary precautions.
Air quality data released by the Health Protection Agency (HPA) shows varying levels of air pollution across different parts of the country. According to the latest readings, Haa Dhaalu Kulhudhuffushi recorded an Air Quality Index (AQI) of 139, while Kaafu Vilimalé recorded an AQI of 107, placing both locations within the “unhealthy for sensitive groups” category.
Shaviyani Funadhoo recorded an AQI reading of 64, categorised as moderate. Kaafu Malé recorded an AQI level of 79, while Dhaalu Kudahuvadhoo recorded 73, both also within the moderate range. Further south, Fuvahmulah and Addu City each recorded AQI readings of 66, indicating moderate air quality levels.
HPA said individuals in areas recording unhealthy and very unhealthy air quality levels face a higher risk of short-term health effects, particularly children, the elderly, pregnant women and those with existing respiratory or cardiovascular conditions. The agency advised residents to limit outdoor activities, wear face masks when outdoors, keep doors and windows closed where possible, and use air purifiers to reduce indoor exposure.
Health authorities also warned that short-term exposure to polluted air may cause irritation of the eyes, nose, throat and lungs, headaches, dizziness, coughing and breathing difficulties, and could worsen existing respiratory or cardiovascular conditions.